Leukemias and constitutional chromosome pathology

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib.

Leukemia·2015

Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.

Leukemia·2015

Differences among young adults, adults and elderly chronic myeloid leukemia patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network.

Transplant infectious disease : an official journal of the Transplantation Society·2013

Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib.

Leukemia·2013

Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study.

British journal of cancer·2012

Neurodegenerative Langerhans cell histiocytosis: building the evidence for prospective monitoring and early treatment. Response to Comment on: "Neurodegenerative Langerhans cell histiocytosis: longterm follow-up of 63 patients from the Italian Registry".

Haematologica·2026

What's liver got to do with it? Hepatic response and survival in AL amyloidosis.

Haematologica·2026

Bridging periodontitis and clonal hematopoiesis: implications for solid tumor metastasis, clinical trial design, and microbiome dynamics. Comment on: "Ligature-induced periodontitis promotes Dnmt3aR878H-driven clonal hematopoiesis".

Haematologica·2026

Comparison and combination of prognostic scores for nodular lymphocytepredominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group.

Haematologica·2026

Elevated on-treatment D-dimer level is associated with major bleeding during extended anticoagulation for venous thromboembolism.

Haematologica·2026

Short-term emicizumab in patients with acquired hemophilia A.

Haematologica·2026

Clinical characteristics, surgical management, and outcomes of uterine smooth muscle tumours of uncertain malignant potential: a single-centre experience.

Przeglad menopauzalny = Menopause review·2026

BCR-ABL1 Transcript Variants in Chronic Myeloid Leukemia Patients in Africa: A Systematic Review.

Health science reports·2026

Classical Hodgkin Lymphoma Today.

Mediterranean journal of hematology and infectious diseases·2026

Jiedu Xiaoliu formula enhances progression-free survival and immune modulation in diffuse large B-cell lymphoma: a retrospective cohort study.

Frontiers in pharmacology·2026

LTF promotes central nervous system leukemia progression via neutrophil serine proteases.

Frontiers in pharmacology·2026

Case Report: refractory hemophagocytic lymphohistiocytosis progression despite complete metabolic response in a patient with stage IV extranodal NK/T-cell lymphoma: clinical observation of "tumor-immune dissociation" phenomenon.

Frontiers in immunology·2026

Related Experiment Videos

Leukemias and constitutional chromosome pathology

Related Concept Videos

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib.

Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.

Differences among young adults, adults and elderly chronic myeloid leukemia patients.

High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network.

Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib.

Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study.

Neurodegenerative Langerhans cell histiocytosis: building the evidence for prospective monitoring and early treatment. Response to Comment on: "Neurodegenerative Langerhans cell histiocytosis: longterm follow-up of 63 patients from the Italian Registry".

What's liver got to do with it? Hepatic response and survival in AL amyloidosis.

Bridging periodontitis and clonal hematopoiesis: implications for solid tumor metastasis, clinical trial design, and microbiome dynamics. Comment on: "Ligature-induced periodontitis promotes Dnmt3aR878H-driven clonal hematopoiesis".

Comparison and combination of prognostic scores for nodular lymphocytepredominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group.

Elevated on-treatment D-dimer level is associated with major bleeding during extended anticoagulation for venous thromboembolism.

Short-term emicizumab in patients with acquired hemophilia A.

Clinical characteristics, surgical management, and outcomes of uterine smooth muscle tumours of uncertain malignant potential: a single-centre experience.

BCR-ABL1 Transcript Variants in Chronic Myeloid Leukemia Patients in Africa: A Systematic Review.

Classical Hodgkin Lymphoma Today.

Jiedu Xiaoliu formula enhances progression-free survival and immune modulation in diffuse large B-cell lymphoma: a retrospective cohort study.

LTF promotes central nervous system leukemia progression via neutrophil serine proteases.

Case Report: refractory hemophagocytic lymphohistiocytosis progression despite complete metabolic response in a patient with stage IV extranodal NK/T-cell lymphoma: clinical observation of "tumor-immune dissociation" phenomenon.

Related Experiment Videos

Leukemias and constitutional chromosome pathology

Related Concept Videos

Related Articles